Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data.

Conclusion: An episode of P. vivax malaria results in high costs to households. The costs of diagnosing and treating P. vivax are important inputs for future cost-effectiveness analyses to ensure optimal allocation of resources for malaria elimination.
PMID: 31819291 [PubMed - in process]

Source: Bulletin of the World Health Organization - November 30, 2019 Category: International Medicine & Public Health Authors: Devine A, Pasaribu AP, Teferi T, Pham HT, Awab GR, Contantia F, Nguyen TN, Ngo VT, Tran TH, Hailu A, Gilchrist K, Green JA, Koh GC, Thriemer K, Taylor WR, Day NP, Price RN, Lubell Y Tags: Bull World Health Organ Source Type: research